CBLL compared with SION: revenue, margins and what each company keeps, and the suppliers and customers both name

CBLLCeribell, Inc.

Mkt capRevenueRevenue

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CBLLCeribell, Inc.

SIONSionna Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CBLL: latest quarter is a loss; flow not drawable. SION: latest quarter not drawable.Method ›

Price

rebased to 0%

CBLL, solidSION, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CBLL 0

None

Shared 0

No disclosed counterparties: CBLL.

Only SION 4

ABBVAbbVie Global Enterprises Ltd. ("AbbVie")supplier

SNYSanofi SA ("Sanofi")supplier

—Galapagosunlistedsupplier

—Cystic Fibrosis Foundation (CFF)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CBLLCeribell, Inc.

26.98▲+1.50%· post 26.98

Mkt cap$1.0BRevenue$28MQ2 FY26Revenue$89MFY25

SIONSionna Therapeutics, Inc.

3.75▼−3.13%· post 3.75

ClosedNov 2 '26

Mkt cap$174.7MRevenue—Revenue—

Compare

ClosedNov 2 '26

CBLLCeribell, Inc.

SIONSionna Therapeutics, Inc.

26.98▲+1.50%post 26.98

Price

3.75▼−3.13%post 3.75

$1.0B

Mkt cap

$174.7M

Q2 FY26$28M

Revenue

—

FY25$89M

Revenue

—

CBLL26.98▲+1.50%vsSION3.75▼−3.13%ClosedNov 2 '26